Sight Sciences Statistics
Want to see SGHT full AI Analyst Report?
Sight Sciences (SGHT) Stock Statistics & Valuation Metrics
Total Valuation
Sight Sciences has a market cap or net worth of $606.92M. The enterprise value is $480.69M.
- Market Cap
- $606.92M
- Enterprise Value
- $480.69M
Share Statistics
Sight Sciences has 55,578,976 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 55,578,976
- Owned by Insiders
- 31.46%
- Owned by Institutions
- 15.20%
Financial Efficiency
Sight Sciences’s return on equity (ROE) is -0.60 and return on invested capital (ROIC) is -35.42%.
- Return on Equity (ROE)
- -0.60
- Return on Assets (ROA)
- -0.33
- Return on Invested Capital (ROIC)
- -35.42%
- Return on Capital Employed (ROCE)
- -0.36
- Revenue Per Employee
- 415.93K
- Profits Per Employee
- -206.59K
- Employee Count
- 186
- Asset Turnover
- 0.67
- Inventory Turnover
- 1.38
Valuation Ratios
The current PE Ratio of Sight Sciences is -20.95. Sight Sciences’s PEG ratio is -0.35.
- PE Ratio
- -20.95
- PS Ratio
- 6.83
- PB Ratio
- 12.18
- Price to FCF
- -35.69
- Price to Operating Cash Flow
- -35.38
- PEG Ratio
- -0.35
Income Statement
In the last 12 months, Sight Sciences had revenue of 77.36M and earned -38.43M in profits. Earnings per share was -0.74.
- Revenue
- 77.36M
- Gross Profit
- 66.67M
- Operating Income
- -37.10M
- Pretax Income
- -38.42M
- Net Income
- -38.43M
- EBITDA
- -32.79M
- Earnings Per Share (EPS)
- -0.74
Cash Flow
In the last 12 months, operating cash flow was -16.92M and capital expenditures 9,000, giving a free cash flow of -16.91M billion.
- Operating Cash Flow
- -16.92M
- Free Cash Flow
- -16.91M
- Free Cash Flow per Share
- -0.31
Dividends & Yields
Sight Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.77%
- Earnings Yield
- -4.69%
Stock Price Statistics
- Beta
- 2.17
- 52-Week Price Change
- 42.36%
- 50-Day Moving Average
- 8.81
- 200-Day Moving Average
- 6.10
- Relative Strength Index (RSI)
- 72.51
- Average Volume (3m)
- 315.69K
Important Dates
Sight Sciences upcoming earnings date is Mar 10, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Mar 10, 2027
- Ex-Dividend Date
- ―
Financial Position
Sight Sciences as a current ratio of 10.22, with Debt / Equity ratio of 63.77%
- Current Ratio
- 10.22
- Quick Ratio
- 9.52
- Debt to Market Cap
- 0.10
- Net Debt to EBITDA
- 1.56
- Interest Coverage Ratio
- -7.21
Taxes
In the past 12 months, Sight Sciences has paid 10.00K in taxes.
- Income Tax
- 10.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
Sight Sciences EV to EBITDA ratio is -23.59, with an EV/FCF ratio of -34.03.
- EV to Sales
- 6.51
- EV to EBITDA
- -23.59
- EV to Free Cash Flow
- -34.03
- EV to Operating Cash Flow
- -34.01
Balance Sheet
Sight Sciences has $77.40M in cash and marketable securities with $42.11M in debt, giving a net cash position of $35.30M billion.
- Cash & Marketable Securities
- $77.40M
- Total Debt
- $42.11M
- Net Cash
- $35.30M
- Net Cash Per Share
- $0.64
- Tangible Book Value Per Share
- $0.89
Margins
Gross margin is 87.74%, with operating margin of -29.52%, and net profit margin of -32.13%.
- Gross Margin
- 87.74%
- Operating Margin
- -29.52%
- Pretax Margin
- -32.06%
- Net Profit Margin
- -32.13%
- EBITDA Margin
- -27.60%
- EBIT Margin
- -27.94%
Analyst Forecast
The average price target for Sight Sciences is $12.70, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $12.70
- Price Target Upside
- 15.56% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 6
- Revenue Growth Forecast
- 16.23%
- EPS Growth Forecast
- 41.47%
Scores
- Smart Score
- 7
- AI Score
- 59
